LISBON -- The addition of insulin to the treatment regimen of type 2 diabetes patients on liraglutide (Victoza) doesn't wipe out previously seen weight loss -- and insulin appears to help these patients achieve glycemic control, researchers said here. more

LISBON -- International guidelines on screening for gestational diabetes that will likely raise the prevalence of the condition have sparked questions over appropriate diagnostic tools and cost efficacy, researchers said here. more

LISBON -- Men with type 2 diabetes and an acute myocardial infarction who score lower on quality-of-life measures have a greater mortality risk than other men with these conditions whose scores indicate they feel better about their health, researchers reported here. more

LISBON -- About 366 million people worldwide have diabetes, according to the latest figures from the International Diabetes Federation, released in advance of a United Nations summit on non-communicable diseases in New York next week. more

LISBON -- Though there's "no major endpoint trial" being presented at this year's European Association for the Study of Diabetes meeting here, executive director Viktor Joergens, MD, said there will be plenty of debate over several recent controversies. more

STOCKHOLM -- The novel once-weekly injectable GLP-1 receptor agonist taspoglutide was better at improving glycated hemoglobin after six months than twice-daily exenatide (Byetta) -- but was plagued by the same gastrointestinal side effects that halted the T-Emerge series of trials, researchers said. more

This survey is a poll of those who choose to participate and are, therefore, not valid statistical samples, but rather a snapshot of what your colleagues are thinking.

ADVERTISEMENT

MedPageToday is a trusted and reliable source for clinical and policy coverage that directly affects the lives and practices of health care professionals.

Physicians and other healthcare professionals may also receive Continuing Medical Education (CME) and Continuing Education (CE) credits at no cost for participating in MedPage Today-hosted educational activities.